US Stock MarketDetailed Quotes
SNOA Sonoma Pharmaceuticals
- 2.9100
- +0.0700+2.46%
Close Nov 21 16:00 ET
- 2.8511
- -0.0589-2.02%
Post 17:55 ET
3.90MMarket Cap-2939P/E (TTM)
3.0700High2.7000Low345.48KVolume2.8600Open2.8400Pre Close1.01MTurnover26.21%Turnover RatioLossP/E (Static)1.34MShares9.374052wk High0.73P/B3.84MFloat Cap2.520052wk Low--Dividend TTM1.32MShs Float72323.1863Historical High--Div YieldTTM13.03%Amplitude2.3180Historical Low2.9140Avg Price1Lot Size
Sonoma Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 90.83%4.08M | -26.95%2.59M | -18.12%3.13M | -18.12%3.13M | -8.66%2.41M | -36.23%2.14M | -36.56%3.54M | -48.35%3.82M | -48.35%3.82M | -69.12%2.63M |
| -Cash and cash equivalents | 90.83%4.08M | -26.95%2.59M | -18.12%3.13M | -18.12%3.13M | -8.66%2.41M | -36.23%2.14M | -36.56%3.54M | -48.35%3.82M | -48.35%3.82M | -69.12%2.63M |
| Receivables | 42.02%3.16M | 33.13%3.25M | -6.59%5.99M | -6.59%5.99M | 25.21%2.88M | -10.62%2.22M | 0.21%2.44M | 34.30%6.42M | 34.30%6.42M | -19.52%2.3M |
| -Accounts receivable | 42.02%3.16M | 33.13%3.25M | 12.67%2.9M | 12.67%2.9M | 25.21%2.88M | -10.62%2.22M | 0.21%2.44M | 6.86%2.57M | 6.86%2.57M | -19.52%2.3M |
| -Taxes receivable | ---- | ---- | -19.48%3.1M | -19.48%3.1M | ---- | ---- | ---- | 62.17%3.85M | 62.17%3.85M | ---- |
| Inventory | 12.89%2.84M | -2.64%2.66M | -4.86%2.72M | -4.86%2.72M | 3.72%2.96M | -16.93%2.51M | -2.08%2.73M | 7.32%2.86M | 7.32%2.86M | -1.04%2.85M |
| Prepaid assets | ---- | ---- | -22.37%340K | -22.37%340K | ---- | ---- | ---- | -41.99%438K | -41.99%438K | ---- |
| Current deferred assets | -11.29%220K | -6.32%237K | 9.17%262K | 9.17%262K | 15.32%256K | 15.35%248K | 17.67%253K | 10.09%240K | 10.09%240K | 5.21%222K |
| Other current assets | -56.11%1.93M | -30.84%3.2M | 320.00%105K | 320.00%105K | 24.12%4.01M | 32.58%4.4M | 21.80%4.62M | -95.97%25K | -95.97%25K | 0.12%3.23M |
| Total current assets | 6.12%12.22M | -12.22%11.93M | -9.06%12.55M | -9.06%12.55M | 11.31%12.5M | -7.08%11.52M | -8.30%13.59M | -16.02%13.8M | -16.02%13.8M | -36.54%11.23M |
| Non current assets | ||||||||||
| Net PPE | -46.74%417K | -38.26%518K | -28.15%651K | -28.15%651K | -5.99%738K | -6.23%783K | 6.61%839K | 3.07%906K | 3.07%906K | -14.86%785K |
| -Gross PPE | -46.74%417K | -38.26%518K | 3.80%3.03M | 3.80%3.03M | -5.99%738K | -6.23%783K | 6.61%839K | 12.74%2.92M | 12.74%2.92M | -14.86%785K |
| -Accumulated depreciation | ---- | ---- | -18.17%-2.38M | -18.17%-2.38M | ---- | ---- | ---- | -17.71%-2.01M | -17.71%-2.01M | ---- |
| Non current deferred assets | -23.00%971K | -16.04%1.17M | 1.44%1.48M | 1.44%1.48M | -18.90%1.3M | -15.71%1.26M | -3.61%1.39M | -0.34%1.45M | -0.34%1.45M | 146.24%1.6M |
| Other non current assets | 1.33%76K | -20.78%61K | -9.59%66K | -9.59%66K | -74.68%78K | -68.49%75K | -31.25%77K | -5.19%73K | -5.19%73K | 310.67%308K |
| Total non current assets | -30.91%1.46M | -24.28%1.75M | -9.91%2.19M | -9.91%2.19M | -21.51%2.12M | -17.52%2.12M | -1.50%2.31M | 0.75%2.43M | 0.75%2.43M | 63.59%2.7M |
| Total assets | 0.37%13.69M | -13.97%13.67M | -9.19%14.74M | -9.19%14.74M | 4.95%14.62M | -8.87%13.64M | -7.37%15.89M | -13.87%16.23M | -13.87%16.23M | -28.01%13.93M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -21.99%770K | -31.10%751K | -27.82%607K | -27.82%607K | -33.64%864K | -8.10%987K | -47.01%1.09M | -48.75%841K | -48.75%841K | -17.75%1.3M |
| -accounts payable | -21.99%770K | -31.10%751K | -27.82%607K | -27.82%607K | -33.64%864K | -8.10%987K | -47.01%1.09M | -48.75%841K | -48.75%841K | -17.75%1.3M |
| Current accrued expenses | 18.80%2.02M | -1.20%2.23M | -3.01%1.42M | -3.01%1.42M | -16.08%1.85M | -4.86%1.7M | 15.52%2.26M | 38.15%1.46M | 38.15%1.46M | 70.36%2.2M |
| Current debt and capital lease obligation | -48.97%198K | -32.77%359K | -24.16%521K | -24.16%521K | -18.48%225K | -24.07%388K | -22.83%534K | -35.07%687K | -35.07%687K | -67.45%276K |
| -Current debt | -52.33%82K | -32.23%204K | -25.06%323K | -25.06%323K | --44K | -24.89%172K | -34.42%301K | -46.66%431K | -46.66%431K | ---- |
| -Current capital lease obligation | -46.30%116K | -33.48%155K | -22.66%198K | -22.66%198K | -34.42%181K | -23.40%216K | 0.00%233K | 2.40%256K | 2.40%256K | 5.75%276K |
| Current deferred liabilities | 96.91%319K | 154.94%413K | 198.75%478K | 198.75%478K | -10.97%138K | 5.88%162K | 5.88%162K | -87.47%160K | -87.47%160K | 1.97%155K |
| Other current liabilities | ---- | ---- | 22.61%694K | 22.61%694K | ---- | ---- | ---- | -27.81%566K | -27.81%566K | ---- |
| Current liabilities | 2.16%3.31M | -7.18%3.75M | 0.05%3.72M | 0.05%3.72M | -21.86%3.07M | -8.17%3.24M | -16.75%4.04M | -36.12%3.72M | -36.12%3.72M | 1.52%3.93M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -65.67%46K | -49.59%61K | -46.30%87K | -46.30%87K | -23.81%160K | -49.05%134K | -53.46%121K | -47.57%162K | -47.57%162K | -41.99%210K |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15K |
| -Long term capital lease obligation | -65.67%46K | -49.59%61K | -46.30%87K | -46.30%87K | -17.95%160K | -45.97%134K | -50.61%121K | -47.57%162K | -47.57%162K | -46.13%195K |
| Non current deferred liabilities | -60.53%45K | -51.52%64K | -37.86%87K | -37.86%87K | -21.09%101K | -17.39%114K | -13.16%132K | -23.08%140K | -23.08%140K | -32.63%128K |
| Total non current liabilities | 6.42%5.02M | 7.31%4.95M | 7.65%4.88M | 7.65%4.88M | 9.40%4.85M | 6.96%4.72M | 6.10%4.61M | 4.80%4.54M | 4.80%4.54M | 3.07%4.44M |
| Total liabilities | 4.69%8.33M | 0.54%8.7M | 4.23%8.6M | 4.23%8.6M | -5.29%7.93M | 0.24%7.96M | -5.96%8.65M | -18.66%8.25M | -18.66%8.25M | 2.34%8.37M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | -60.00%2K | -60.00%2K | -60.00%2K | 0.00%2K | -50.00%1K | 150.00%5K | 150.00%5K | 150.00%5K | -33.33%2K |
| -common stock | --0 | -60.00%2K | -60.00%2K | -60.00%2K | 0.00%2K | -50.00%1K | 150.00%5K | 150.00%5K | 150.00%5K | -33.33%2K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -1.92%-196.1M | -2.39%-195.49M | -2.55%-194.35M | -2.55%-194.35M | -2.70%-193.28M | -3.30%-192.42M | -3.07%-190.93M | -2.79%-189.51M | -2.79%-189.51M | -3.74%-188.21M |
| Paid-in capital | 2.21%205.65M | 1.49%204.07M | 1.15%203.21M | 1.15%203.21M | 2.45%202.8M | 1.78%201.21M | 1.77%201.08M | 1.79%200.9M | 1.79%200.9M | 0.40%197.94M |
| Gains losses not affecting retained earnings | -34.52%-4.2M | -23.98%-3.6M | 20.33%-2.72M | 20.33%-2.72M | 32.40%-2.82M | 29.27%-3.12M | 33.58%-2.91M | 20.73%-3.42M | 20.73%-3.42M | 8.64%-4.18M |
| Total stockholders'equity | -5.69%5.35M | -31.30%4.98M | -23.07%6.14M | -23.07%6.14M | 20.38%6.69M | -19.17%5.68M | -9.01%7.24M | -8.28%7.98M | -8.28%7.98M | -50.23%5.56M |
| Total equity | -5.69%5.35M | -31.30%4.98M | -23.07%6.14M | -23.07%6.14M | 20.38%6.69M | -19.17%5.68M | -9.01%7.24M | -8.28%7.98M | -8.28%7.98M | -50.23%5.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
